{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:17:21Z","timestamp":1791303441389,"version":"4.1.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013700","name":"National Comprehensive Cancer Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.brachy.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T08:15:27Z","timestamp":1663229727000},"page":"726-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Partial breast irradiation: An updated consensus statement from the American brachytherapy society"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7645-2159","authenticated-orcid":false,"given":"Bethany","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1744-6271","authenticated-orcid":false,"given":"Mitchell","family":"Kamrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kuske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3200-0534","authenticated-orcid":false,"given":"Daniel","family":"Scanderbeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Shaitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catheryn","family":"Yashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.brachy.2022.07.004_bib0001","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ijrobp.2020.11.006","article-title":"Breast-Conserving Surgery Followed by Partial or Whole Breast Irradiation: Twenty-Year Results of a Phase 3 Clinical Study","volume":"109","author":"Polgar","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0002","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0003","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomized, Phase III, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0004","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomized controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0005","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomized, controlled, Phase III, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0006","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ijrobp.2013.08.046","article-title":"Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation","volume":"87","author":"Rodriguez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0007","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized Phase III APBI-IMRT-Florence Trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0008","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijrobp.2004.04.012","article-title":"Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis","volume":"60","author":"Vicini","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0009","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomized, Phase III trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardization of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomized controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2016.06.019","article-title":"GEC-ESTRO multicenter Phase III-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance","volume":"120","author":"Ott","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0012","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(18)30195-5","article-title":"Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomized, Phase III trial","volume":"19","author":"Schafer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0013","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2013.09.009","article-title":"A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer","volume":"87","author":"Garsa","year":"2013","journal-title":"Intern J Radiation Oncol Biology Physics"},{"key":"10.1016\/j.brachy.2022.07.004_bib0014","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","volume":"18","author":"Polgar","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/cncr.21289","article-title":"First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial","volume":"104","author":"Vicini","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2022.07.004_bib0016","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjsurg.2007.06.010","article-title":"Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer","volume":"194","author":"Benitez","year":"2007","journal-title":"Am J Surg"},{"key":"10.1016\/j.brachy.2022.07.004_bib0017","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.ijrobp.2010.12.023","article-title":"Association between maximal skin dose and breast brachytherapy outcome: a proposal for more rigorous dosimetric constraints","volume":"81","author":"Cuttino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijrobp.2013.05.039","article-title":"Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity","volume":"88","author":"Vargo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0019","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2014.08.341","article-title":"Long-term results from the Contura multilumen balloon breast brachytherapy catheter Phase IV registry trial","volume":"90","author":"Cuttino","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.brachy.2016.07.002","article-title":"Strut-based accelerated partial breast irradiation: report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study","volume":"15","author":"Yashar","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0021","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2022.07.004_bib0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brachy.2021.10.003","article-title":"American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy","volume":"21","author":"Shah","year":"2022","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.brachy.2022.07.004_bib0023","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.brachy.2020.10.011","article-title":"Breast brachytherapy","volume":"20","author":"Strnad","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2009.01.041","article-title":"Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation","volume":"76","author":"Jagsi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0025","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","article-title":"Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy","volume":"31","author":"Olivotto","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0026","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.ijrobp.2009.01.009","article-title":"Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation","volume":"75","author":"Hepel","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0027","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijrobp.2014.12.040","article-title":"Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis","volume":"91","author":"Peterson","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0028","article-title":"APBI with 3D-CRT vs. WBI: cosmetic and toxicity results of the prospective randomised IRMA trial","author":"Meduri","year":"2020","journal-title":"ESTRO"},{"issue":"15","key":"10.1016\/j.brachy.2022.07.004_bib0029","article-title":"Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39\/RTOG 0413 accelerated partial breast irradiation (APBI) trial","volume":"29","author":"Julian JPC","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2016.08.042","article-title":"Long-term update of NRG oncology RTOG 0319: a Phase I and II trial to evaluate 3-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I and II breast carcinoma","volume":"96","author":"Rabinovitch","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1S","key":"10.1016\/j.brachy.2022.07.004_bib0031","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2019.06.384","article-title":"Cosmetic outcome from post lumpectomy Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) on the NRG Oncology\/NSABP B39-RTOG 0413 Phase III clinical trial","volume":"105","author":"White KW","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0032","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ijrobp.2020.11.044","article-title":"Once daily versus twice daily external beam accelerated partial breast irradiation: a randomized prospective study","volume":"109","author":"Boutrus","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0033","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.18.00982","article-title":"Patient-reported outcomes over 5 years after whole- or partial-breast radiotherapy: longitudinal analysis of the IMPORT LOW (CRUK\/06\/003) Phase III randomized controlled trial","volume":"37","author":"Bhattacharya","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0034","unstructured":"Radiologists RCo. Postoperative radiotherapy for breast cancer: hypofractionation RCR consensus statements. 2021. Available at: www.rcr.ac.uk. access date August 4, 2022."},{"key":"10.1016\/j.brachy.2022.07.004_bib0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a Phase III randomized controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2022.07.004_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2017.01.023","article-title":"Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: health-related quality of life final analysis from the Florence Phase III trial","volume":"76","author":"Meattini","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2022.07.004_bib0037","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.adro.2020.03.013","article-title":"Breast Radiation Therapy Under COVID-19 pandemic resource constraints-approaches to defer or shorten treatment from a comprehensive cancer center in the United States","volume":"5","author":"Braunstein","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0038","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ijrobp.2021.07.047","article-title":"OPAR: a multicenter Phase II randomized trial of fractionation schedules for once-a-day Accelerated Partial Breast Irradiation (APBI)","volume":"11","author":"Kim","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0039","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijrobp.2020.05.025","article-title":"Risk factors for fat necrosis after stereotactic partial breast irradiation for early-stage breast cancer in a Phase I clinical trial","volume":"108","author":"Rahimi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0040","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ijrobp.2021.01.015","article-title":"Cosmetic outcomes of a Phase I dose escalation study of 5-fraction stereotactic partial breast irradiation for early stage breast cancer","volume":"110","author":"Rahimi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2022.07.004_bib0041","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ijrobp.2021.10.010","article-title":"Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer","volume":"112","author":"Rahimi","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0042","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijrobp.2020.02.021","article-title":"Single-institution Phase I\/II prospective clinical trial of single-fraction, high-gradient adjuvant partial-breast irradiation for hormone sensitive Stage 0-I breast cancer","volume":"107","author":"Kennedy","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0043","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.radonc.2021.09.023","article-title":"Implementing stereotactic accelerated partial breast irradiation using magnetic resonance guided radiation therapy","volume":"164","author":"Price","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0044","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.brachy.2017.11.008","article-title":"Accelerated partial breast irradiation for suitable elderly women using a single fraction of multicatheter interstitial high-dose-rate brachytherapy: early results of the Single-Fraction Elderly Breast Irradiation (SiFEBI) Phase I\/II trial","volume":"17","author":"Hannoun-Levi","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.brachy.2014.04.005","volume":"13","author":"Jones","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0046","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/COC.0000000000000402","article-title":"Six-year results from a Phase I\/II trial for hypofractionated accelerated partial breast irradiation using a 2-day dose schedule","volume":"41","author":"Wilkinson","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0047","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2018.12.050","article-title":"Three-Fraction Accelerated Partial Breast Irradiation (APBI) delivered with brachytherapy applicators is feasible and safe: first results from the TRIUMPH-T Trial","volume":"104","author":"Khan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0048","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijrobp.2021.07.049","article-title":"Three-fraction TRIUMPH-T brachytherapy for delivery of APBI offers effective disease control with minimal late toxicity","volume":"111","author":"Yashar","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0049","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2018.12.025","article-title":"Three-fraction intracavitary accelerated partial breast brachytherapy: early provider and patient-reported outcomes of a novel regimen","volume":"104","author":"Jethwa","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.brachy.2020.10.010","article-title":"Very accelerated partial breast irradiation Phase I-II multicenter trial (VAPBI): feasibility and early results","volume":"20","author":"Guinot","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0051","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13014-019-1448-0","article-title":"Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly","volume":"14","author":"Kinj","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0052","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brachy.2019.10.007","article-title":"Accelerated partial breast irradiation in the elderly: 5-Year results of the single fraction elderly breast irradiation (SiFEBI) Phase I\/II trial","volume":"19","author":"Hannoun-Levi","year":"2020","journal-title":"Brachytherapy"},{"issue":"7","key":"10.1016\/j.brachy.2022.07.004_bib0053","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jgo.2021.04.009","article-title":"Quality of life and Comprehensive Geriatric Assessment (CGA) in older adults receiving Accelerated Partial Breast Irradiation (APBI) using a single fraction of Multi-Catheter Interstitial High-Dose Rate Brachytherapy (MIB). The SiFEBI phase I\/II trial","volume":"12","author":"Boulahssass","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2022.07.004_bib0054","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2021.03.052","article-title":"APBI Versus Ultra-APBI in the Elderly With Low-Risk Breast Cancer: A Comparative Analysis of Oncological Outcome and Late Toxicity","volume":"111","author":"Hannoun-Levi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0055","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.brachy.2020.05.002","article-title":"Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT","volume":"19","author":"Meneveau","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0056","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2016.04.035","article-title":"A novel form of breast intraoperative radiation therapy with CT-guided high-dose-rate brachytherapy: results of a prospective Phase I clinical trial","volume":"96","author":"Showalter","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0057","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/1754-9485.12790","article-title":"Utility of CT imaging in a novel form of high-dose-rate intraoperative breast radiation therapy","volume":"62","author":"Hassinger","year":"2018","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"9","key":"10.1016\/j.brachy.2022.07.004_bib0058","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1245\/s10434-020-09526-y","article-title":"Ultra-Short Fraction Schedules as Part of De-intensification Strategies for Early-Stage Breast Cancer","volume":"28","author":"Shah","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0059","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.brachy.2014.05.014","article-title":"The rationale, technique, and feasibility of partial breast irradiation using noninvasive image-guided breast brachytherapy","volume":"13","author":"Hepel","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0060","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2020.07.2312","article-title":"Phase II trial of Accelerated Partial Breast Irradiation (APBI) using Noninvasive Image Guided Breast Brachytherapy (NIBB)","volume":"108","author":"Hepel","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0061","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.brachy.2018.05.006","article-title":"Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: feasibility and acute toxicity","volume":"17","author":"Hepel","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0062","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.brachy.2021.01.002","article-title":"Multi-institutional registry study evaluating the feasibility and toxicity of accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy","volume":"20","author":"Hepel","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0063","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.brachy.2019.04.003","article-title":"Permanent breast seed implant for partial breast radiotherapy after partial mastectomy for favorable breast cancer: technique, results, and applications to various seroma presentations","volume":"18","author":"Crook","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0064","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijrobp.2015.07.2266","article-title":"Report on the clinical outcomes of permanent breast seed implant for early-stage breast cancers","volume":"93","author":"Pignol","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0065","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomized controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2022.07.004_bib0066","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(21)00080-2","article-title":"Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial","volume":"22","author":"Orecchia","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0067","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","article-title":"Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomized, non-inferiority Phase III trial","volume":"376","author":"Vaidya","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0068","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-a randomized trial","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0069","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.0249","article-title":"Effect of delayed targeted intraoperative radiotherapy vs. whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-a randomized clinical trial in early breast cancer","volume":"6","author":"Vaidya","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0070","doi-asserted-by":"crossref","first-page":"m2836","DOI":"10.1136\/bmj.m2836","article-title":"Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-a randomized clinical trial","volume":"370","author":"Vaidya","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.brachy.2022.07.004_bib0071","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1245\/s10434-020-09432-3","article-title":"TARGIT-R (Retrospective): 5-year follow-up evaluation of Intraoperative Radiation Therapy (IORT) for breast cancer performed in North America","volume":"28","author":"Valente","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0072","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijrobp.2016.04.024","article-title":"Cosmesis and breast-related quality of life outcomes after intraoperative radiation therapy for early breast cancer: a substudy of the TARGIT-a trial","volume":"96","author":"Corica","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0073","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-013-2641-8","article-title":"Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomized controlled trial","volume":"140","author":"Keshtgar","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.brachy.2022.07.004_bib0074","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S0140-6736(14)60825-4","article-title":"Radiotherapy for breast cancer, the TARGIT-A trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2022.07.004_bib0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Investigators PI. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomized controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0076","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.brachy.2022.07.004_bib0077","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1245\/s10434-020-09356-y","article-title":"Intraoperative radiation therapy for breast cancer: are we there yet?","volume":"28","author":"Shah","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0078","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.brachy.2018.10.006","article-title":"The American Brachytherapy Society consensus statement for electronic brachytherapy","volume":"18","author":"Tom","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0079","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1118\/1.2357021","article-title":"Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray Source: an electronic brachytherapy source","volume":"33","author":"Rivard","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0080","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1245\/s10434-017-5934-z","article-title":"Intraoperative radiation using low-kilovoltage X-rays for early breast cancer: a single site trial","volume":"24","author":"Silverstein","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0081","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1245\/s10434-018-6614-3","article-title":"Intraoperative Radiation Therapy (IORT): a series of 1000 tumors","volume":"25","author":"Silverstein","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0082","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1245\/s10434-016-5316-y","article-title":"Acute and chronic complications in breast cancer patients treated with intraoperative radiation therapy","volume":"23","author":"Epstein","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0083","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/COC.0b013e31825493bb","article-title":"Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year","volume":"36","author":"Patel","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0084","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1245\/s10434-010-1283-x","article-title":"Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer","volume":"18","author":"Ivanov","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/OTT.S15297","article-title":"Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis","volume":"4","author":"Dooley","year":"2011","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.brachy.2022.07.004_bib0086","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijrobp.2006.06.041","article-title":"Accelerated partial-breast irradiation using proton beams: initial clinical experience","volume":"66","author":"Kozak","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0087","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijrobp.2014.04.008","article-title":"Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a Phase I trial","volume":"90","author":"Galland-Girodet","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0088","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2014.05.1308","article-title":"Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes","volume":"90","author":"Bush","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0089","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.radonc.2013.06.008","article-title":"Phase II trial of proton beam accelerated partial breast irradiation in breast cancer","volume":"108","author":"Chang","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0090","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijrobp.2014.06.039","article-title":"Initial clinical experience using protons for accelerated partial-breast irradiation: longer-term results","volume":"90","author":"Strom","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0091","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijrobp.2020.09.009","article-title":"Proton accelerated partial breast irradiation: clinical outcomes at a planned interim analysis of a prospective Phase II trial","volume":"109","author":"Pasalic","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0092","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13014-019-1417-7","article-title":"3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen","volume":"14","author":"Mutter","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0093","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.radonc.2016.11.009","article-title":"The changing landscape in radiotherapy for breast cancer: lessons from long term follow-up in some European breast cancer trials","volume":"121","author":"Bartelink","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0094","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejca.2017.06.014","article-title":"Preoperative breast radiation therapy: indications and perspectives","volume":"82","author":"Lightowlers","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2022.07.004_bib0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ijrobp.2019.12.037","article-title":"Five-year results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) trial","volume":"106","author":"Bosma","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0096","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ijrobp.2015.03.007","article-title":"Preoperative single-fraction partial breast radiation therapy: a novel Phase I, dose-escalation protocol with radiation response biomarkers","volume":"92","author":"Horton","year":"2015","journal-title":"Intern J Radiation Oncol Biology Physics"},{"key":"10.1016\/j.brachy.2022.07.004_bib0097","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2019.11.406","article-title":"Tumor response after neoadjuvant magnetic resonance guided single ablative dose partial breast irradiation","volume":"106","author":"Vasmel","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0098","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1148\/radiology.200.3.8756906","article-title":"Capsular contracture after lumpectomy and radiation therapy in patients who have undergone uncomplicated bilateral augmentation mammoplasty","volume":"200","author":"Mark","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.brachy.2022.07.004_bib0099","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/j.prro.2020.01.003","article-title":"Feasibility of breast-conservation therapy and hypofractionated radiation in the setting of prior breast augmentation","volume":"10","author":"Tadros","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0100","series-title":"American Brachytherapy Society Annual Meeting","first-page":"S4","article-title":"APBI Using Brachytherapy in the presence of breast augmentation: 320 women","author":"Blitzer","year":"2021"},{"key":"10.1016\/j.brachy.2022.07.004_bib0101","unstructured":"NCCN Guidelines Version 2. 2021."},{"issue":"2","key":"10.1016\/j.brachy.2022.07.004_bib0102","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijrobp.2020.12.029","article-title":"Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database","volume":"110","author":"Hannoun-Levi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0103","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.breast.2020.01.003","article-title":"Second conservative treatment for second ipsilateral breast tumor event: a systematic review of the different re-irradiation techniques","volume":"49","author":"Montagne","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.brachy.2022.07.004_bib0104","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.05.035","article-title":"Partial breast irradiation as second conservative treatment for local breast cancer recurrence","volume":"60","author":"Hannoun-Levi","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.brachy.2014.05.017","article-title":"Long-term follow up of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence","volume":"13","author":"Trombetta","year":"2014","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2022.07.004_bib0106","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","article-title":"Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology\/RTOG 1014 Phase 2 Clinical Trial","volume":"6","author":"Arthur","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0107","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-019-05221-z","article-title":"GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event","volume":"176","author":"Montagne","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.brachy.2022.07.004_bib0108","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.brachy.2016.08.012","article-title":"Locoregional recurrence by molecular subtype after multicatheter interstitial accelerated partial breast irradiation: results from the Pooled Registry Of Multicatheter Interstitial Sites research group","volume":"15","author":"Anderson","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0109","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brachy.2017.10.009","article-title":"Outcomes by molecular subtype after accelerated partial breast irradiation using single-entry catheters","volume":"17","author":"Saini","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.617439","article-title":"Outcomes after accelerated partial breast irradiation in women with triple negative subtype and other \"High Risk\" variables categorized as cautionary in the ASTRO guidelines","volume":"11","author":"Goulding","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0111","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijrobp.2010.12.031","article-title":"Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation","volume":"81","author":"Wilkinson","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0112","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ijrobp.2009.08.081","article-title":"Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status","volume":"78","author":"Wilder","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clbc.2016.07.010","article-title":"Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation","volume":"17","author":"Wilkinson","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.brachy.2022.07.004_bib0114","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2022.07.004_bib0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10549-019-05238-4","article-title":"Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)","volume":"176","author":"Bellon","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.brachy.2022.07.004_bib0116","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2009.23.7610","article-title":"Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20","volume":"28","author":"Mamounas","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0117","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in Stages I and II invasive breast cancer","volume":"32","author":"Moran","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0118","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","article-title":"Society of surgical oncology-american society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"34","author":"Morrow","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0119","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1245\/s10434-020-08878-9","article-title":"The diminishing impact of margin definitions and width on local recurrence rates following breast-conserving therapy for early-stage invasive cancer: a meta-analysis","volume":"27","author":"Shah","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0120","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0121","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0122","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0123","unstructured":"The American Society of Breast Surgeons: Consensus Guideline on Breast Cancer Lumpectomy Margins. 2018."},{"key":"10.1016\/j.brachy.2022.07.004_bib0124","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a Phase III randomized controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0125","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/COC.0000000000000334","article-title":"Outcomes of node-positive breast cancer patients treated with accelerated partial breast irradiation via multicatheter interstitial brachytherapy: the Pooled Registry of Multicatheter Interstitial Sites (PROMIS) experience","volume":"41","author":"Kamrava","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0126","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ijrobp.2014.04.039","article-title":"Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy","volume":"89","author":"Jobsen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.07.004_bib0127","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1524-4741.2012.01271.x","article-title":"Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation","volume":"18","author":"Freedman","year":"2012","journal-title":"Breast J"},{"issue":"8","key":"10.1016\/j.brachy.2022.07.004_bib0128","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/1097-0142(20010415)91:8+<1679::AID-CNCR1183>3.0.CO;2-8","article-title":"Fifteen-year prognostic discriminants for invasive breast carcinoma: national Surgical Adjuvant Breast and Bowel Project Protocol-06","volume":"91","author":"Fisher","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2022.07.004_bib0129","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2001.19.6.1688","article-title":"Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials","volume":"19","author":"Voogd","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","article-title":"The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation","volume":"17","author":"Shah","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.07.004_bib0131","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/annonc\/mdm268","article-title":"Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer","volume":"18","author":"Colleoni","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2022.07.004_bib0132","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.brachy.2019.01.015","article-title":"The American Brachytherapy Society consensus statement on intraoperative radiation therapy","volume":"18","author":"Tom","year":"2019","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:18:37Z","timestamp":1761531517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472122001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1538472122001192"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2022.07.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial breast irradiation: An updated consensus statement from the American brachytherapy society","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}